Skip to content
OpenCapital
Get started

International Flavors & Fragrances IFF Pharma Solutions — Adjusted Operating EBITDA

Discontinued — last reported Q2 '25

Similar metrics at other companies

AptarGroup logo
ATRPharma — Adjustedincomelossfromcontinuingoperationsbeforeinterestexpenseinterestincomeincometaxesdepreciationamortizationextraordinaryitemsnoncontrollinginterestsnet
$111.01M+4.7%
AptarGroup logo
ATRPharma — Adjusted EBITDA
$146.22M+2.6%
BrightSpring Health Services, Inc. logo
BTSGPharmacy Solutions — Earnings Before Interest Income Taxes Depreciation And Amortization From Reportable
$169.07M+46.1%
Element Solutions logo
ESIPerformance Solutions — Operating Income Loss Adjusted Earnings Before Interest Taxes Depreciation And Amortization
$108.3M+0.5%
Baxter International logo
BAXPharmaceuticals — Segment operating income
$46M-27.0%
AptarGroup logo
ATRPharma — Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
6,050,200,000%+833,300,000pp

Other financials

Income statement

See full
Revenue$2.7B-3.6%
Gross profit$1.0B-1.6%
Operating income$273.0M+130%
Net income$169.0M+117%
EPS (diluted)$0.66+117%

Balance sheet

See full
Cash & equivalents$562.0M-13.5%
Total debt$6.3B-35.5%
Total equity$14.1B+7.2%
Total assets$25.1B-11.0%

Cash flow

See full
Operating cash flow$257.0M+102%
CapEx$165.0M-7.8%
Free cash flow$92.0M+277%

Valuation

See full
Market cap$19.59B-6.6%
Enterprise value$25.37B-16.2%
P/E23.9×—
P/S1.8×0.0×

Profitability

See full
Gross margin36.3%+0.2pp
Operating margin-3.2%-1.4pp
Net margin7.6%+5.2pp
FCF margin3.7%-1.3pp

Returns & leverage

See full
Return on equity6%+4.0pp
Debt / equity0.4×-0.3×
Current ratio1.5×-0.4×

Where this comes from

Reported directly by International Flavors & Fragrances in its filing.

Tagged under the XBRL concept iff:SegmentAdjustedOperatingEBITDA.

The official record: International Flavors & Fragrances’s 10-Q, filed August 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about International Flavors & Fragrances's pharma solutions — adjusted operating ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is International Flavors & Fragrances's pharma solutions — adjusted operating EBITDA?
International Flavors & Fragrances (IFF) reported pharma solutions — adjusted operating EBITDA of $22M in Q2 2025.
How has International Flavors & Fragrances's pharma solutions — adjusted operating EBITDA changed year-over-year?
International Flavors & Fragrances's pharma solutions — adjusted operating EBITDA decreased by 62.1% year-over-year, from $58M to $22M.
What is the long-term trend for International Flavors & Fragrances's pharma solutions — adjusted operating EBITDA?
Over 3 years (2021 to 2024), International Flavors & Fragrances's pharma solutions — adjusted operating EBITDA has grown at a 9.2% compound annual growth rate (CAGR), from $165M to $215M.
What does pharma solutions — adjusted operating EBITDA mean?
The core operating profit of the Pharma Solutions segment, adjusted to exclude non-cash and non-recurring items.
How do you interpret pharma solutions — adjusted operating EBITDA?
An increase indicates improved operational profitability and cash generation, while a decrease signals margin pressure or operational challenges.
How does pharma solutions — adjusted operating EBITDA compare across companies?
Widely used by investors to compare segment-level performance across diversified industrial and chemical companies.